drug

Treating Zika Infection: Repurposed Drugs Show Promise

Thursday, September 8, 2016

While wearing protective clothing, a researcher in a lab at NCATS dispenses Zika virus into trays for compound screening using procedures that follow strict biosafety standards.

By testing 6,000 FDA-approved drugs and experimental chemical compounds on Zika-infected human cells in the lab, a team that includes IRP scientists has shown that some existing drugs might be repurposed to fight Zika infection and prevent the virus from harming the developing brain.

Early Women Scientists of NIH, Part 2

Friday, April 8, 2016

Like many in the second wave of women scientists at the National Institutes of Health, Dr. Margaret Kelly began as a technician and got her PhD while she was working. Kelly focused on what caused cancer and what drugs could be used to fight it.

Back to the Future of Brain Research

Friday, December 19, 2014

“Here is an image that is historical because it represents the era (1980s and 1990s) when drug receptors were first being localized in the brain," writes Miles Herkenham, Ph.D.

Herkenham Cannabinoid receptor hippocampus